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Autologous transfusion has been used to overcome adverse
effects of homologous transfusion. Clinical studies evaluating
general orthopaedic postoperative results have been designed
to compare these transfusion methods. However, few studies
have evaluated postoperative results in spinal fusion surgeries,
which have larger blood loss volumes. The purpose of this
study is to determine if there are differences in postoperative
infection and clinical results of spinal fusion with autologous,
as compared to homologous, blood transfusion. A total of 62
patients who underwent instrumented spinal fusion and re-
ceived autologous (n = 30) or homologous (n = 32) transfusions
were reviewed. Information on gender, age, preoperative and
3-day postoperative hematologic features, total transfused
units, segmental estimated blood loss, transfused units, and
surgery time were collected. In addition, postoperative infec-
tion data on wound infection, pneumonia, urinary tract infec-
tion, cellulitis, and viral disease, incidence and duration of
fever, as well as clinical results, fusion rates, and patient feed-
back were collected. No differences in postoperative infection
and clinical results were found between the two types of
transfusions; however, homologous transfusion was associated
with an increased number of total units transfused, longer
duration of fever, and decreased patient satisfaction regarding
the transfusion.
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INTRODUCTION
Major orthopedic surgical procedures, including
hip arthroplasty, may result in significant blood
loss.1,2 Certain procedures, especially spinal
fusions, require relatively large amounts of trans-
fusion due to long operative duration, bleeding
from the bone graft bed, and spinal instrumen-
tation.3,4
In spite of developments in transfusion medi-
cine, several complications are directly related to
homologous blood transfusion. Although infec-
tious contamination has declined substantially, the
most common risk remains viral hepatitis, with a
transmission rate of approximately 1 per 100,000
units transfused.5
Autologous transfusion (preoperative blood
deposit and retransfusion) has been proposed to
overcome adverse effects of homologous transfu-
sion. Advantages include elimination of viral
infection, transfusion-related lung injury, anaphy-
laxis, graft-versus-host disease, alloimmunization,
and Rh sensitization.6 Autologous transfusions
have been used in major orthopaedic procedures,
including hip and knee arthroplasties, and, since
the introduction of spinal surgery in the 1970s, it
continues to be used.3,7-12,14-18
Previous clinical studies have evaluated autolo-
gous transfusion combined with hypotensive
anesthesia,19 hemodilution,20 replacement time,21
and efficacy.14,22 Several studies have also ex-
amined differences in postoperative results, com-
pared to homologous transfusion, in hysterec-
tomies,
23
general orthopedic surgeries,
24
and hip
arthroplasties.25 Surprisingly, few studies have
evaluated postoperative infection and clinical
results in spinal fusions, which tend to have the
largest volumes of blood loss.
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The purpose of this study is to determine
whether postoperative infection and clinical re-
sults differ between patients receiving autologous
or homologous blood in instrumented spinal
fusion.
MATERIALS AND METHODS
We reviewed medical records of patients who
underwent transfusion and instrumented spinal
fusion for spinal stenosis or spondylolisthesis
between January 1, 1999, and December 31, 2000.
Spinal stenosis without spondylolisthesis and
spondylolisthesis alone occurred in 41 (66%) and
21 (34%) patients, respectively. Operations were
performed by the same surgeons and anesthe-
siologist. All patients provided informed consent.
Autologous or homologous blood transfusion
only, occurred in 30 and 32 procedures, respec-
tively. Twenty five patients who received both
autologous and homologous blood were excluded
from the study. Patients with high infection risk,
including steroid therapy, malnutrition, obesity,
diabetes mellitus, and immunosuppression, were
not included.
Criteria for autologous donation included a
preparticipation screening hemoglobin value; at
least 110 grams per liter. Phlebotomy was per-
formed weekly and completed at least five days
prior to surgery. Donation was delayed if hemo-
globin was less than 110 grams per liter at any
time during the blood-acquisition process. Oral
iron administration was initiated prior to donation
and continued for approximately two months.
In accordance with recently established red
blood-cell transfusion guidelines,26 absolute indi-
cation for transfusion included intra- or post-
operative hemoglobin less than 70 grams per liter.
However, most patients received transfusion for
clinically based signs and laboratory findings
consistent with symptomatic anemia; defined as
hemoglobin less than 100 grams per liter, and
associated with persistent tachycardia refractory
to intravenous fluids, orthostatic hypotension,
dyspnea on exertion, or profound fatigability that
precluded physical therapy.
We collected information on gender, age, hemo-
globin, hematocrit, preoperative and 3-day post-
operative platelet count, segmental estimated
Table 1. Criteria for Measuring Improvement of Clinical Results
Excellent Complete relief of pain in back and lower limbs
No limitation of physical activity
Analgesics not used
Able to squat on the floor
Good Relief of most pain in back and lower limbs
Able to return to accustomed employment
Physical activities slightly limited
Analgesics used only infrequently
Able to squat on the floor
Fair Partial relief of pain in back and lower limbs
Able to return to accustomed employment with limitation or return to lighter work
Poor Physical activities definitely limited
Mild analgesic medication used frequently
Mild limitation to squat on the floor
Little or no relief of pain in back and lower limbs
Physical activities greatly limited
Unable to return to accustomed employment
Analgesics medication used frequently
Unable to squat on the floor without support
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blood loss, transfused units, surgery time, total
transfused units, and duration of prophylactic
systemic antibiotic therapy. Segmental estimated
blood loss, time, and transfused units in surgery
are defined as total blood loss, time, and trans-
fused units divided by number of fused vertebrae,
respectively.
Information on postoperative infections, such as
wound infection, pneumonia, urinary tract infec-
tion, cellulitis, and viral transmitted disease, and
incidence and duration of fever without identified
infection, was collected. Additional collected in-
formation included postoperative clinical results,
fusion rates, and satisfaction for the transfusion.
Criteria used for postoperative infection were
those used by Tartter et al.27,28 Purulent exudate
and positive cultures were adequate evidence of
postoperative wound infection. Urinary tract in-
fection was diagnosed when more than 105
colonies grew from culture. Fever, leukocytosis,
and chest infiltrate indicated pneumonia. Fever
was defined by temperature more than 38.3 (101
). Duration of fever was calculated in days.25
Clinical results were analyzed by Kim's criteria,
according to clinical improvement variables (Table
1).29 Solid fusion is defined by continuous trabe-
cular bridge traversing the grafted segment
between the transverse processes by flexion and
extension dynamogram.30,31 Patient satisfaction
was classified as "satisfied," "unsatisfied," and "not
judged," by asking patient discomfort during and
after transfusion, compared to before transfusion.
Statistical analysis was performed using SPSS
10. The independent-samples t test, chi-square
test, and Pearson correlation analysis were used to
compare variables. P value less than 0.05 was con-
sidered significant.
RESULTS
Autologous and homologous recipients were
similar in gender, age, segmental time in surgery,
estimated blood loss, number of transfused units,
number of fused vertebrae, duration of antibiotic
therapy, and mean hospital stay. Homologous
transfusion was associated with an increased total
number of units transfused (Table 2). Usually the
recommended duration for prophylactic antibiotic
administration upon spinal surgery is two days;32
however, longer durations are common practice at
our institution.
The autologous and homologous recipients
were similar in hemoglobin, hematocrit, and
platelet count preoperatively and at the 3rd post-
operative day (Table 3).
No statistical differences were found in post-
operative infections including wound infection,
Table 2. Clinical Features of Patients with Autologous and Homologous Transfusion
Autologous Homologous p value
Number 30 32
Sex (M/F) 13/17 16/16
Age (yrs) 53.6 ± 12.7 56.9 ± 6.9 NS*
Seg. time in surgery (min) 142.6 ± 43.9 144.6 ± 67.0 NS
Seg. estimated blood loss (mL) 475.8 ± 216.9 561.7 ± 124.7 NS
Seg. transfused units 1.7 ± 0.8 2.2 ± 0.9 NS
Number of fused vertebrae 1.3 ± 0.2 1.5 ± 0.2 NS
Total transfused units 2.0 ± 0.7 3.5 ± 1.8 0.001
Days on IV antibiotics 7 7
Mean hospital length of stay 10.2 9.7 NS
The values shown are mean ± SD unless otherwise noted.
The p values were determined by independent-samples t test, level 5%.
*Not significant.
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pneumonia, urinary tract infection, or cellulites,
although one patient in the autologous group
developed postoperative wound infection, and
one developed viral infection (the common cold)
(Table 4).
No differences were found in incidence of fever
without identified infection; however, homolo-
gous transfusion was associated with longer fever
duration (Table 4), which, in turn, was associated
with an increased total number of units transfused
(Pearson correlation 0.448, p-value 0.015).
No differences were found in improvement of
postoperative clinical results or fusion rates, but
autologous transfusion was associated with in-
creased satisfaction (Table 5, 6).
DISCUSSION
The purpose of this study is to determine
whether differences in postoperative infection and
clinical results occurred between those receiving
autologous or homologous transfusion during
spinal fusion.
Most large series evaluating postoperative
wound infection in spinal surgery report an
overall rate of less than 1%.
33-35
The incidence of
postoperative wound infections depends on
operative methods, times, and preoperative con-
ditions; it decreases with simple procedures, good
vascularity, and prophylactic systemic antibiotics,
and increases with more fusions. Instrumented
spinal fusion procedures involve more extensive
Table 4. Postoperative Complications of Patients with Autologous and Homologous Transfusion
Autologous (n = 30) Homologous (n = 32) p value
Postop. Infection 1 0 NS*
Wound infection 0 0
UTI 0 0
Pneumonia 0 0
Cellulitis 0 0
Viral infection 1 0
Incidence of fever 19 (63.3%) 20 (62.5%) NS*
Days of fever 1.63 ± 0.68 3.00 ± 1.73 0.005
*Not significant.
The values shown are mean ± SD.
The p values were determined by independent-samples t test, level 5%.
Table 3. Laboratory Features of Patients with Autologous and Homologous Transfusion
Autologous Homologous p value
Preop. Hb (gm/dL) 12.5 ± 1.3 13.3 ± 1.5 NS*
Preop. Hct (%) 37.1 ± 4.1 39.6 ± 4.2 NS
Preop. Platelet (× 103/ L)μ 221.6 ± 73.4 271.7 ± 54.7 NS
PO. 3d Hb (gm/dL) 10.4 ± 1.3 11.0 ± 1.7 NS
PO. 3d Hct (%) 30.0 ± 3.8 31.5 ± 4.5 NS
PO. 3d Platelet (× 103/ L)μ 225.9 ± 54.8 280.9 ± 103.7 NS
The values shown are mean ± SD.
The p values were determined by independent-samples t test, level 5%.
*Not significant.
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soft tissue dissection, longer operative times,
greater blood loss, greater dead space, and in-
creased soft tissue damage from poor vascu-
larity.35 We targeted patients with instrumented
procedures because of the greater possibility of
postoperative infection.
Triulzi et al.36 reported that patients who re-
ceived both types of transfusions had a signifi-
cantly greater rate of postoperative bacterial infec-
tion, compared to those with autologous blood
only, 20.8% vs. 3.3%, respectively. Among patients
with postoperative bacterial infections, surgery to
address scoliosis was the most common surgical
procedure (6/8) used in this study.
36
Usually, the
scoliosis surgical procedure results in larger blood
loss volumes than in spinal stenosis and spondy-
lolisthesis surgical procedures. In these cases,
autologous transfusion is usually not sufficient for
replacement, and additional homologous blood is
usually required.37 Therefore, we targeted spinal
fusion for spinal stenosis or spondylolisthesis, as
homologous transfusion after autologous transfu-
sion is usually not needed in such cases.
As postoperative wound infection in spinal
surgery is less than 1%, we evaluated postopera-
tive infection, including wound infection, pneu-
monia, urinary tract infection, cellulitis, and viral
disease.
There has been reported increase risk of post-
operative infection in patients receiving homolo-
gous blood, compared to those receiving autolo-
gous blood, in orthopaedic24 and hip arthroplastic
surgeries.25 Triulzi et al.36 reported an increased
rate of postoperative bacterial infection in patients
who received homologous blood, compared to
those who received no blood (20.8 vs. 4.0%). In-
creased postoperative infection during homolo-
gous transfusion was correlated with a higher
level of plasma immunosuppressive factor,38 drop
in natural killer cells,36 decrease in the number of
auxiliary CD4 lymphocytes,39 increase in the
number of CD8 suppressor lymphocytes, 39 and
suppressed cell-mediated immunity.40
However, in our report, no differences were
found among cases of postoperative infections,
including wound infection, pneumonia, urinary
tract infection, and cellulites. Recipients of
homologous blood were not at increased risk of
infection, compared to autologous blood re-
cipients in a study evaluating hysterectomies.
23
In
cases of suppressed immunity, such as burn in-
cidents, sepsis, or trauma, it was found that
homologous transfusions were immunosuppres-
sive.41-43 However, it has been demonstrated that
homologous transfusions produced mild immu-
nostimulation in cases of normal immunity in an
Table 5. Postoperative Clinical Results of Patients with Autologous and Homologous Transfusion
Autologous (n = 30) Homologous (n = 32)
Excellent 21 (70%) 26 (81.3%)
Good 6 (20%) 4 (12.4%)
Fair 3 (10%) 2 (6.3%)
Poor 0 (0%) 0 (0%)
Chi-Square test, p value = 0.710.
Table 6. Overall Satisfaction for Transfusion in the Autologous and Homologous Transfused Groups
Autologous (n = 30) Homologous (n = 32)
Satisfied 23 (76.7%) 4 (12.6%)
Unsatisfied 4 (13.3%) 26 (81.1%)
Not judged 3 (10.0%) 2 (6.3%)
Chi-square test, p value = 0.001.
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untraumatized, nonseptic rodent model.44 It is also
reported that postoperative wound infection is
affected mainly by systemic immunosuppression,
such as occurs in trauma and sepsis.44 Many
studies report that postoperative wound infection
is common in immunosuppressed patients.27,41-43,45
No differences in incidence of fever without
source was found, but homologous transfusion
was associated with longer fever duration. Non-
hemolytic febrile transfusion reactions and febrile
allergic reactions are more common with homolo-
gous than autologous transfusion but do not
generally result in serious morbidity.46 Murphy et
al.25 reported that patients who received homolo-
gous blood and those who received autologous
blood did not differ in total number of transfused
units and fever duration (1.1 vs. 1.3 days). Differ-
ences in our report may be because the total
number of transfused units was greater in patients
with homologous than autologous transfusion.
The common outcome predictors of surgery for
spinal stenosis are preoperative walking ability,
co-morbidity, such as cardiovascular disease, and
increased dural sac cross-sectional area by decom-
pression.47,48 No differences were found in post-
operative clinical results, because autologous
transfusion likely did not improve walking ability
and cardiovascular function. However, autologous
transfusion was associated with increased satis-
faction since it decreased total number of units
transfused and fever duration.
Limitations of this retrospective and compara-
tive study include a non-randomized design, as
patients were not allowed to donate at low
hemoglobin values.
Our finding suggests that autologous transfu-
sion does not result in decreased incidence of
postoperative infection. However, its use may
enhance recovery to the level of average daily
living activity by increasing satisfaction due to
fewer total units transfused and shorter fever
duration.
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